Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-14-000007

← back to feed
Filed
May 6, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Apr 4, 2014 111.55M sh
Operating Cash Flow Q3 2014 · Mar 31, 2014 −$20.44K
Operating Cash Flow Q3 2014 · Mar 31, 2014 −$84.29K
Operating Cash Flow Q3 2014 · Mar 31, 2014 −$2.17M
Cash And Equivalents Q3 2014 · Mar 31, 2014 $1.01K
Cash And Equivalents Q3 2014 · Jun 30, 2013 $7.05K
Stockholders Equity Q3 2014 · Mar 31, 2014 −$2.16M
Stockholders Equity Q3 2014 · Jun 30, 2013 −$2.05M
Total Liabilities Q3 2014 · Mar 31, 2014 $2.17M
Total Liabilities Q3 2014 · Jun 30, 2013 $2.07M
Current Assets Q3 2014 · Mar 31, 2014 $6.47K
Current Assets Q3 2014 · Jun 30, 2013 $12.26K
Net Income Q3 2014 · Mar 31, 2014 −$20.14K
Net Income Q3 2014 · Mar 31, 2014 −$83.47K
Net Income Q3 2014 · Mar 31, 2014 −$2.15M
Operating Income Q3 2014 · Mar 31, 2014 −$20.14K
Operating Income Q3 2014 · Mar 31, 2014 −$83.47K
Operating Income Q3 2014 · Mar 31, 2014 −$2.43M